ClinicalTrials.gg
Sign In

Myopia, Degenerative clinical trials

The registry lists 71 studies for Myopia, Degenerative across more than 10 countries. 20 are recruiting or about to start. 50 of them are mainly about Myopia, Degenerative (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-14.

Get an email when these change. Save the Myopia, Degenerative studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
20
Active, not recruiting
15
Status unknown
13
Recruiting
9
Not yet recruiting
9
Withdrawn
3

Phase

Phase 3
10
Phase 2
7
Phase 1
5
Early Phase 1
1

Where

China
25
United States
9
United Kingdom
4
Taiwan
4
Singapore
4
Pakistan
3

Who runs them

Shanghai Eye Disease Prevention and Treatment Center (7) · Zhongshan Ophthalmic Center, Sun Yat-sen University (4) · Beijing Airdoc Technology Co., Ltd. (4) · Tianjin Eye Hospital (4) · Menicon Co., Ltd. (3) · Novartis Pharmaceuticals (2) · Cloudbreak Therapeutics, LLC (1) · National Taiwan University Hospital (1)

What is being tested here

Drugs under test in Myopia, Degenerative studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ranibizumab025
Atropine002
Trabedersen011
Carboxymethylcellulose001
Glycerol001
Aflibercept011
Fosbretabulin001
Bevacizumab001
Ophthalmic Solutions001

Drug classes tested here Angiogenesis inhibitors 7

Coming up

4phase 3 studies under way
9studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9, phase 3 first

Who these studies take

Of the 9 Myopia, Degenerative studies recruiting now, 1 (11%) set no upper age limit and 7 (78%) stop at 75 or younger. 7 (78%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (33%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
106 (67%)6 (67%)
180 (0%)0 (0%)
301 (11%)1 (11%)
402 (22%)2 (22%)
502 (22%)2 (22%)
652 (22%)2 (22%)
752 (22%)2 (22%)
852 (22%)2 (22%)

Across all 71 studies, recruiting or not: 75% stop at 75 or younger and 75% at 65; 70% take children; 0% are for women only and 0% for men only; 42% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Myopia, Degenerative studies take

Of 30 interventional studies with no phase under Myopia, Degenerative, half reached primary completion within 40 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase40 mo30–96 · 30 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 71. Browse all 71 → or search them.